• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Section Contents Menu

Newsroom

FDA PRESS RELEASE

For Immediate Release: April 5, 2012
Media Inquiries: Tamara Ward, Tamara.Ward@hhs.fda.gov, 301-796-7567
Consumer Inquiries: 888-INFO-FDA

 

Update: On April 16, the FDA received information that the UPC code for the 200 g package of Crispy Almond Cookies listed in the original release was obsolete. The correct UPC code for Crispy Almond Cookies 200 g is 6 27265 00522 1.

 

FDA warns consumers not to eat Crispy brand cookies and rusk manufactured by TWI Foods Inc., Ontario, Canada
Products may contain undeclared allergens

Fast Facts
• TWI Foods Inc., of Mississauga, Ontario, Canada is voluntarily recalling Crispy brand cookies and rusk, a hard crisp bread.
• The recalled products may contain two of the eight most common allergens, milk and almonds.
• Allergic reactions to food can sometimes cause serious illness and death.
• Consumers should stop using the product if they have allergies to milk or almonds, call their doctor and follow the additional instructions in “What Do Consumers and Others Need To Do” below.

What is the Problem?
TWI Foods Inc. is voluntarily recalling several varieties of Crispy brand cookies and rusk.  The Food and Drug Administration (FDA) along with the Canadian Food Inspection Agency (CFIA) and TWI Foods Inc., are warning people with allergies to milk or almonds not to consume Crispy brand cookie and rusk products. The affected products contain almonds and/or milk which are not clearly declared on the label.

What are the Symptoms of Illness/Injury?
Food allergy symptoms typically appear from within minutes to up to two hours after a person has eaten the food to which they are allergic. Allergic reactions can include: hives, flushed skin or rash, tingling or itchy sensation in the mouth, face, tongue, or lip swelling, vomiting and/or diarrhea, abdominal cramps, coughing or wheezing, dizziness and/or lightheadedness, swelling of the throat and vocal cords, difficulty breathing, and/or a drop in blood pressure.

Who is at Risk?
Consumers with allergies to milk and/or almonds are at risk. Although most food allergies cause relatively mild and minor symptoms, some food allergies can cause severe reactions, and may even be life-threatening. There is no cure for food allergies.

What Do Consumers Need To Do? 
Strict avoidance of food allergens and early recognition and management of allergic reactions to food are important measures to prevent serious health consequences.

Consumers who think they may have become ill from eating cookies or rusk with milk and/or almonds should consult their health care providers.

The following products were shipped to the US:

Product
UPC
Size
Crispy Pistachio Cookies
6 27265 00601 3
400 g
Crispy Pistachio Cookies
6 27265 00161 2
200 g
Crispy Almond Cookies
6 27265 00120 9
400 g
Crispy Almond Cookies
6 27265 00522 1
200 g
Crispy Coconut Cookies
6 27265 00121 6
400 g
Crispy Coconut Cookies
6 27265 00521 4
200 g
Crispy Almond Cake Rusk
6 27265 00217 6
750 g

Where is it Distributed?  
The Canadian-manufactured cookies products were sent to 28 United States distributors in 15 states including California, Colorado, Florida, Georgia, Illinois, Texas, Virginia, Maryland, Massachusetts, New Jersey, New Mexico, New York, Ohio, Oregon, and Washington.

Have There Been Any Illnesses Reported?
There have been no illnesses reported at this time.
      
What is Being Done about the Problem?
FDA is monitoring the problem in collaboration with the CFIA and public health agencies in those states where the products have been distributed.

Who Should be Contacted?
For more information, consumers and industry can call the CFIA at 1-800-442-2342/TTY 1-800-465-7735 (8:00 a.m. to 8:00p.m. EST, Monday through Friday).

For information on milk and nuts, two of the eight most common food allergens, please click on the link below:
http://www.foodsafety.gov/blog/foodallergy2011.html

The information in this press release reflects the FDA’s best efforts to communicate what it has learned from the manufacturer and the state and local public health agencies involved in the investigation. The agency will update this page as more information becomes available.

For more information:

http://www.inspection.gc.ca/english/corpaffr/recarapp/2012/20120329e.shtml
http://www.inspection.gc.ca/english/corpaffr/recarapp/2012/20120329e.shtml#photos
#